183 related articles for article (PubMed ID: 15561098)
1. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
Agner J; Falck J; Lukas J; Bartek J
Exp Cell Res; 2005 Jan; 302(2):162-9. PubMed ID: 15561098
[TBL] [Abstract][Full Text] [Related]
2. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
[TBL] [Abstract][Full Text] [Related]
3. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
Jin J; Ang XL; Ye X; Livingstone M; Harper JW
J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
[TBL] [Abstract][Full Text] [Related]
4. DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells.
Koledova Z; Kafkova LR; Krämer A; Divoky V
Stem Cells; 2010 Mar; 28(3):450-61. PubMed ID: 20104581
[TBL] [Abstract][Full Text] [Related]
5. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint.
Hassepass I; Voit R; Hoffmann I
J Biol Chem; 2003 Aug; 278(32):29824-9. PubMed ID: 12759351
[TBL] [Abstract][Full Text] [Related]
7. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy.
Xiao Z; Xue J; Sowin TJ; Zhang H
Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813
[TBL] [Abstract][Full Text] [Related]
8. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
[TBL] [Abstract][Full Text] [Related]
9. Enhanced 7-ethyl-10-hydroxycamptothecin (SN-38) lethality by methylselenocysteine is associated with Chk2 phosphorylation at threonine-68 and down-regulation of Cdc6 expression.
Yin MB; Li ZR; Cao S; Durrani FA; Azrak RG; Frank C; Rustum YM
Mol Pharmacol; 2004 Jul; 66(1):153-60. PubMed ID: 15213307
[TBL] [Abstract][Full Text] [Related]
10. The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.
Zhang Y; Qu D; Morris EJ; O'Hare MJ; Callaghan SM; Slack RS; Geller HM; Park DS
J Neurosci; 2006 Aug; 26(34):8819-28. PubMed ID: 16928871
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Sampath D; Shi Z; Plunkett W
Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
13. [Degradation of Cdc25A phosphatase in HeLa cells under normal and stress conditions].
Goloudina AR; Aksenov ND; Pospelov VA
Tsitologiia; 2004; 46(5):423-30. PubMed ID: 15344887
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.
Zhao H; Watkins JL; Piwnica-Worms H
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14795-800. PubMed ID: 12399544
[TBL] [Abstract][Full Text] [Related]
15. Rapid destruction of human Cdc25A in response to DNA damage.
Mailand N; Falck J; Lukas C; Syljuâsen RG; Welcker M; Bartek J; Lukas J
Science; 2000 May; 288(5470):1425-9. PubMed ID: 10827953
[TBL] [Abstract][Full Text] [Related]
16. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.
Sørensen CS; Syljuåsen RG; Falck J; Schroeder T; Rönnstrand L; Khanna KK; Zhou BB; Bartek J; Lukas J
Cancer Cell; 2003 Mar; 3(3):247-58. PubMed ID: 12676583
[TBL] [Abstract][Full Text] [Related]
17. The regulatory beta-subunit of protein kinase CK2 accelerates the degradation of CDC25A phosphatase through the checkpoint kinase Chk1.
Kreutzer J; Guerra B
Int J Oncol; 2007 Nov; 31(5):1251-9. PubMed ID: 17912454
[TBL] [Abstract][Full Text] [Related]
18. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
19. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.
Uto K; Inoue D; Shimuta K; Nakajo N; Sagata N
EMBO J; 2004 Aug; 23(16):3386-96. PubMed ID: 15272308
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cells are capable of executing G1/S checkpoint activation.
Bárta T; Vinarský V; Holubcová Z; Dolezalová D; Verner J; Pospísilová S; Dvorák P; Hampl A
Stem Cells; 2010 Jul; 28(7):1143-52. PubMed ID: 20518019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]